Clinical Research Unit Nanoro Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2011
NCT01210040
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Clinical Research Unit Nanoro (CRUN) | Institut de Recherche en sciences de la Santé - Unité de Recherche Clinique de Nanoro (IRSS-URCN), Burkina Faso | Unité de Recherche Clinique, CMA St Camille, Nanoro, Burkina Faso

Active Ingredients

Drugs in Phase 3 Trials (2)

artemether (1 trial)

lumefantrine (Coartem) (1 trial)

Drugs in Other Trials (2)

folic acid (1 trial)

iron (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Body Weight (Phase 3)

Malaria (Phase 3)

Malaria, Falciparum (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 4